ACS CAN’s third annual public policy conference will take place on April 29, 2014 in Washington, D.C. The overall goal is to create a forum for leaders in business, academia, public policy, patient advocacy, as well as other key stakeholders to capture the latest and best thinking about the impact of personalized medicine on patients – particularly people living with cancer.
Focus of the conference
Our 2014 policy conference will focus on the promise of personalized medicine and what it can mean for patients in a rapidly changing health care system. While most stakeholders agree that the goal of personalized medicine is to provide the right therapy to treat the right patient at the right time, much remains to be done in order to achieve this goal. Patients are at the heart of personalized medicine, and the Forum will focus on what patients with serious diseases like cancer want and expect from care that is tailored to their unique disease. Specifically, the conference will examine:
• What are patient expectations for personalized medicine?
• How can cancer patients benefit from genetic testing and targeted therapies?
• How do we ensure that personalized medicine is practiced in a reliable way that optimizes patient outcome?
• What is needed to integrate personalized medicine into clinical practice, including in community settings?
• What are the barriers to patients accessing personalized medicine?
• What is needed to continue to promote new advances in personalized medicine?
The conference will be held at:
Washington Marriott at Metro Center
775 12th Street NW
Washington, DC 20005
For more information, please click here.